These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Goshajinkigan reduces oxaliplatin-induced peripheral neuropathy without affecting anti-tumour efficacy in rodents. Ushio S; Egashira N; Sada H; Kawashiri T; Shirahama M; Masuguchi K; Oishi R Eur J Cancer; 2012 Jun; 48(9):1407-13. PubMed ID: 21907570 [TBL] [Abstract][Full Text] [Related]
3. Oxaliplatin acts on IB4-positive nociceptors to induce an oxidative stress-dependent acute painful peripheral neuropathy. Joseph EK; Chen X; Bogen O; Levine JD J Pain; 2008 May; 9(5):463-72. PubMed ID: 18359667 [TBL] [Abstract][Full Text] [Related]
4. Thermal hyperalgesia as a marker of oxaliplatin neurotoxicity: a prospective quantified sensory assessment study. Attal N; Bouhassira D; Gautron M; Vaillant JN; Mitry E; Lepère C; Rougier P; Guirimand F Pain; 2009 Aug; 144(3):245-252. PubMed ID: 19457614 [TBL] [Abstract][Full Text] [Related]
5. An effective therapeutic approach for oxaliplatin-induced peripheral neuropathy using a combination therapy with goshajinkigan and bushi. Mizuno K; Shibata K; Komatsu R; Omiya Y; Kase Y; Koizumi S Cancer Biol Ther; 2016 Nov; 17(11):1206-1212. PubMed ID: 27416484 [TBL] [Abstract][Full Text] [Related]
6. Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel. Xiao WH; Zheng H; Bennett GJ Neuroscience; 2012 Feb; 203():194-206. PubMed ID: 22200546 [TBL] [Abstract][Full Text] [Related]
7. [Role of Transient Receptor Potential Channels in Paclitaxel- and Oxaliplatin-induced Peripheral Neuropathy]. Taguchi K Yakugaku Zasshi; 2016; 136(2):287-96. PubMed ID: 26831807 [TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors. Descoeur J; Pereira V; Pizzoccaro A; Francois A; Ling B; Maffre V; Couette B; Busserolles J; Courteix C; Noel J; Lazdunski M; Eschalier A; Authier N; Bourinet E EMBO Mol Med; 2011 May; 3(5):266-78. PubMed ID: 21438154 [TBL] [Abstract][Full Text] [Related]
9. Pain in oxaliplatin-induced neuropathy--sensitisation in the peripheral and central nociceptive system. Binder A; Stengel M; Maag R; Wasner G; Schoch R; Moosig F; Schommer B; Baron R Eur J Cancer; 2007 Dec; 43(18):2658-63. PubMed ID: 17855072 [TBL] [Abstract][Full Text] [Related]
10. Behavioral and immunohistological assessment of painful neuropathy induced by a single oxaliplatin injection in the rat. Ling B; Coudoré-Civiale MA; Balayssac D; Eschalier A; Coudoré F; Authier N Toxicology; 2007 May; 234(3):176-84. PubMed ID: 17418472 [TBL] [Abstract][Full Text] [Related]
11. Oxaliplatin-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia. Sakurai M; Egashira N; Kawashiri T; Yano T; Ikesue H; Oishi R Pain; 2009 Dec; 147(1-3):165-74. PubMed ID: 19782472 [TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin-Induced Neuropathy: A Long-Term Clinical and Neurophysiologic Follow-Up Study. Kokotis P; Schmelz M; Kostouros E; Karandreas N; Dimopoulos MA Clin Colorectal Cancer; 2016 Sep; 15(3):e133-40. PubMed ID: 27038553 [TBL] [Abstract][Full Text] [Related]
13. Roles of Transient Receptor Potential Ankyrin 1 in Oxaliplatin-Induced Peripheral Neuropathy. Nakagawa T; Kaneko S Biol Pharm Bull; 2017; 40(7):947-953. PubMed ID: 28674258 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of single doses of elcatonin and pregabalin on oxaliplatin-induced cold and mechanical allodynia in rats. Aoki M; Kurauchi Y; Mori A; Nakahara T; Sakamoto K; Ishii K Biol Pharm Bull; 2014; 37(2):322-6. PubMed ID: 24492729 [TBL] [Abstract][Full Text] [Related]
15. Oxaliplatin treatment changes the function of sensory nerves in rats. Yamamoto S; Ono H; Kume K; Ohsawa M J Pharmacol Sci; 2016 Apr; 130(4):189-93. PubMed ID: 26790975 [TBL] [Abstract][Full Text] [Related]
16. Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity. Minami T; Takeda M; Sata M; Kato H; Yano K; Sakai T; Tsujita R; Kawasaki K; Ito A Eur J Pharmacol; 2020 Aug; 880():173196. PubMed ID: 32416186 [TBL] [Abstract][Full Text] [Related]
17. Gabapentin prevents oxaliplatin-induced mechanical hyperalgesia in mice. Ohsawa M; Otake S; Murakami T; Yamamoto S; Makino T; Ono H J Pharmacol Sci; 2014; 125(3):292-9. PubMed ID: 24990115 [TBL] [Abstract][Full Text] [Related]
18. Topical Oxaliplatin Produces Gain- and Loss-of-Function in Multiple Classes of Sensory Afferents. Saleque N; Vastani N; Gentry C; Andersson DA; Israel MR; Bevan S J Pain; 2024 Jan; 25(1):88-100. PubMed ID: 37524219 [TBL] [Abstract][Full Text] [Related]
19. Cold aggravates abnormal excitability of motor axons in oxaliplatin-treated patients. Bennedsgaard K; Ventzel L; Grafe P; Tigerholm J; Themistocleous AC; Bennett DL; Tankisi H; Finnerup NB Muscle Nerve; 2020 Jun; 61(6):796-800. PubMed ID: 32133655 [TBL] [Abstract][Full Text] [Related]
20. Comparison of oxaliplatin- and cisplatin-induced painful peripheral neuropathy in the rat. Joseph EK; Levine JD J Pain; 2009 May; 10(5):534-41. PubMed ID: 19231296 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]